866545-96-2 Usage
General Description
1-(5-Bromo-7-azaindole)ethanone, also known as 5-Bromo-7-azaindole-1-carboxylic acid ethyl ester, is a chemical compound with the molecular formula C9H7BrN2O. It is a derivative of azaindole, a heterocyclic organic compound, and is commonly used in pharmaceutical research and drug development. The compound is known for its potential as a building block in the synthesis of various biologically active molecules, and it has been studied for its potential as a precursor to new drugs. Its structure and properties make it a valuable tool for medicinal chemistry and drug discovery research. It is important to handle and use this compound with care, as it may pose health or environmental hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 866545-96-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,5,4 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 866545-96:
(8*8)+(7*6)+(6*6)+(5*5)+(4*4)+(3*5)+(2*9)+(1*6)=222
222 % 10 = 2
So 866545-96-2 is a valid CAS Registry Number.
866545-96-2Relevant articles and documents
TRICYCLIC DLK INHIBITORS AND USES THEREOF
-
Page/Page column 65-66, (2016/09/26)
The invention relates to compounds of formula (I) and salts thereof, wherein ring A and R1-R2 have any of the values defined in the specification. The compounds and salts are useful for treating DLK mediated disorders. The invention also provides pharmaceutical compositions comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, as well as methods of using said compounds, salts, or compositions as DLK inhibitors and for treating neurodegeneration diseases and disorders.
IMIDAZOPYRIDIN-2-ONE DERIVATIVES
-
Page/Page column 65, (2011/04/24)
A compound represented by formula (I) having mTOR inhibitory activity or a pharmacologically acceptable salt thereof.
PYRROLO-PYRIDINE KINASE MODULATORS
-
Page/Page column 77-78, (2008/12/04)
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.